Chen B, Zhong J, Li X, Pan F, et al. Efficacy and Safety of Ivarmacitinib in Patients with Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study. Gastroenterology 2022 Aug 10. pii: S0016-5085(22)00918.
PMID: 35963369